News

Polycab India shares rose 3.5 percent to Rs 5,078 at noon on March 05 after Morgan Stanley projected a nearly 52 percent upside in the stock. The brokerage assigned an "highweight" rating with a price target of Rs 7,395 per share, citing strong demand in the cables and wires segment. According to Morgan Stanley, Polycab's recent roadshows show that demand has picked up during the fourth quarter and exports have gained positive momentum. The company expects exports to contribute over 10 percent of its revenues over the next five years, aided by the US imposing import duties on competitors such as China and Mexico. The brokerage expects limited disruption in the industry over the next four to five years despite the recent entry of UltraTech Cement into the segment. Scaling the cable b...

New Delhi, March 5: Gold prices on Wednesday rose by Rs 44 to Rs 86,070 per 10 gram in futures trade as speculators created fresh deals amid strong spot demand.Gold contracts for April delivery rose by Rs 44, or 0.05 per cent, to Rs 86,070 per 10 gram on the Multi Commodity Exchange in a business turnover of 14,715 lots.Analysts said fresh buying by participants led to the rise in gold prices.Globally, gold futures rose 0.20 per cent to USD 2,926.40 an ounce in New York.

Shares of Tata Motors and Tata Investments rose up to 3 per cent on March 4, amid reports that Tata Capital, the financial services arm of the Tata Group, is eyeing a valuation of $11 billion for its upcoming public offering. While Tata Motors holds about 4 per cent stake in Tata Capital, Tata Investments holds about 2 per cent equity, which means a higher valuation for the company would bode well for the other two Tata Group companies. Meanwhile, Tata Investments (TICL) also acts as the investment arm of the Tata Group, holding stakes in several Tata companies. Hence, any major development at the group level, such as Tata Capital's IPO, boosts TICL's prospects, as it benefits indirectly from the rising valuation of its portfolio companies. In this sense, shares of Tata Investmen...

Gross GST collections rose 9.1% to around ₹1.84 lakh crore in February, boosted by domestic consumption and indicating a possible economic revival. On a gross basis, ₹35,204 crore came from Central GST, ₹43,704 crore from State GST, ₹90,870 crore from Integrated GST and ₹13,868 crore from compensation cess, according to official data released on Saturday. GST revenue from domestic transactions rose 10.2% to ₹1.42 lakh crore during February, while that from imports rose 5.4% to ₹41,702 crore. Total refunds issued during February were ₹20,889 crore, up 17.3% compared to the year-ago period. Net GST collections during February 2025 grew 8.1% to nearly ₹1.63 lakh crore. Gross and net GST revenues in February 2024 were ₹1.68 lakh crore and ₹1.50 lakh crore, respectively. Gross GST ...

IndiGo share price: Shares of InterGlobe Aviation, the country's largest airline operator, rose 1.78% to hit an intraday high of ₹4,520, amid weak market conditions as the company further consolidated its dominance in the Indian skies. The company's market share in the aviation market rose to 65.2% in January from 64.4% in the previous month. IndiGo also recorded the highest on time performance (OTP) at 75.5%, while Akasa Air's was at 71.5% in January, data from the Directorate General of Civil Aviation showed. Meanwhile, domestic air traffic in January grew 11.28% from a year earlier to 14.6 million, according to official data. Akasa Air and SpiceJet's market share increased by 4.7% and 3.2%, respectively. The number of passengers carried by domestic airlines during January 2...

Leading AI chipmaker Nvidia Corp saw its stock fall 8.5% on Thursday - the biggest drop in a month - after delivering quarterly results that were strong but failed to meet investors' sky-high expectations. The company guided for fiscal first-quarter sales of about $43 billion, slightly ahead of analysts' average estimate of $42.3 billion but below some high estimates that had reached $48 billion. The drop in share price comes after concerns that demand for Nvidia's AI chips could slow due to spending cuts by data center operators. Additional to the pressure, Nvidia warned that profit margins could be lower than estimates due to the acceleration of the rollout of its new Blackwell chip architecture. The company also faces potential challenges from U.S. tariffs that could impact futur...

Global demand for liquefied natural gas (LNG) will increase by 60% by 2040, according to Shell's LNG Outlook 2025, released today. The growth forecast is driven mainly by economic growth in Asia, industrial emissions reduction initiatives and energy requirements for artificial intelligence technologies. Industry analysts now estimate that LNG demand will reach between 630-718 million tonnes annually by 2040, an upward revision from previous estimates. This comes as global LNG trade grows by just 2 million tonnes to 407 million tonnes in 2024, marking the slowest annual growth in ten years due to limited new supply growth. "The world will need more gas for power generation, heating and cooling, industry and transport to meet growth and decarbonisation targets," said Tom Summers, seni...

Gland Pharma shares rose nearly 5 percent on February 25, its best day in 16 weeks, ahead of its investor meet during the analyst day with Emkay and BOB Capital on February 27-28. Business daily Livemint had reported in February quoting sources that Blackstone, Brookfield and Warburg Pincus were in talks to acquire a majority stake in generic injectables maker Gland Pharma. The deal between the three global private equity majors and Shanghai-based Fosun Pharma - which owns a majority stake - is expected to value Gland Pharma at around $3 billion. Gland Pharma's performance in the December quarter has been disappointing, with revenue growth in its core business being weak. The injectables company also faced challenges from its recently acquired Senexi business, which impacted its ...

Shares of drugmaker, Pfizer Ltd outperformed in an otherwise weak market. The stock of the multinational drugmaker listed on Indian exchanges rose 9% and hit an intraday high of ₹4,477 on the NSE after the company on Friday announced that it has entered into a marketing and supply agreement with Mylan Pharmaceuticals Pvt Ltd. Pfizer said it has entered into an agreement with Mylan for a period of five years to market and sell two brands Ativan and Pacitane in India. Ativan is a drug used to treat anxiety in adults and children aged 12 years and above. It also treats insomnia caused by anxiety in adults while Pacitane is indicated to treat Parkinson's disease and extrapyramidal symptoms. "Mylan has a strong presence in the central nervous system therapy space, with skilled resources ...

NHPC shares on Friday rose over 10 per cent for the third consecutive session, surging over 10 per cent following positive brokerage reports on the state-owned hydropower firm. NHPC shares rose nearly 3 per cent to hit an intraday high of Rs 82.16. This is the third consecutive day the stock is trading in the green. On Thursday, the stock gained 6.94 per cent. Over 2.57 crore shares of the stock were exchanged today, taking the total turnover to Rs 209.35 crore, as per NSE data. This sharp surge was witnessed after CLSA upgraded the stock from 'perform' to 'outperform' rating, indicating positive levers for growth. In an exclusive interview to Moneycontrol, Raj Kumar Chaudhary, chairman and managing director of the public sector undertaking (PSU), told NHPC that it will commissio...